Skip to content
Screener

MaxCyte MXCT Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$8.87M+28.2%-$4.75M+53.7%-$9.6M+9.4%-$12.42M-7.4%-$12.36M-31.8%
$978K-11.1%$1.05M-4.5%$1.07M+1.4%$1.07M+0.6%$1.1M+1.8%
$1.16M-67.0%$1.14M-62.5%$706K-77.5%$1.95M-42.0%$3.51M-1.4%
-$4.66M+52.7%-$8.17M+43.3%-$2.69M+65.6%-$7.46M-69.8%-$9.85M-104%
$62K-89.4%$72K-89.0%$231K+57.1%$300K-26.1%$584K+98.6%
$6.57M+327%$2.66M-72.1%$9.68M$5.19M+43.9%$1.54M-92.1%
-$1.42M-1,022%$5K-98.7%$105K-74.5%$14K-93.9%$154K-78.4%
-$5.51M-22.4%-$2.25M-306%-$8.16M
-$4.72M+54.7%-$8.24M+45.3%-$2.92M+63.4%-$7.76M-61.7%-$10.44M-104%

FAQ

How much cash does MaxCyte generate?
MaxCyte (MXCT) generated -$23.0M in operating cash flow over the trailing twelve months.
What is MaxCyte's free cash flow?
After $665.0K of capital expenditures, MaxCyte's free cash flow was -$23.6M over the trailing twelve months, up 38.2% year over year.
Where does MaxCyte's cash flow data come from?
Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.